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Background. Very little is known about the economic burden of eating disorders (ED) and related mental health
comorbidities.
Methods. Using 5 years of data from the U.S. Medical Expenditures Panel Survey, we estimated the difference in
annual health care costs, employment status, and earned income (2011 US$) between individuals with current
ED compared to those without ED. We further estimated the contribution of mental health comorbidities to
these disparities in health care costs, employment and earnings.
Results. Individualswith ED had greater annual health care costs ($1869, p= 0.012), lower but borderline signif-
icant employment rates (OR = 0.67, 95% CIs [0.41, 1.09]), and lower but not statistically signiﬁcant earnings
among those who were employed ($2093, p = 0.48), compared to individuals without ED. Among individuals
with ED, the presence of mental health comorbidities was associated with higher but not statistically signiﬁcant
health care costs ($1993, p = 0.17), lower borderline signiﬁcant odds of employment (OR= 0.41, 95% CIs [0.14,
1.20]), and signiﬁcantly lower earnings ($19,374, p b 0.01).
Conclusions. Treatment and prevention of EDmay have broader economic beneﬁts in terms of heath care savings
and gains inwork productivity than previously recognized. This exploratory study justiﬁes large scale evaluations
of the societal economic impact of eating disorders and comorbidities.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Eating disorders (ED) are relatively rare in the general population,
but those affected often require long-term expensive treatment. Nearly
half of all individualswith ED suffer frommental health comorbidities at
some point during their lives, including anxiety, major depressive or
other mood disorders, and behavioral disorders (Hudson et al., 2007;
Swanson et al., 2011). While several economic evaluations have
assessed the cost of ED treatment (Stuhldreher, 2012), the costs of
treating mental health comorbidities have received little attention.
Recent studies have also begun tomeasure the non-health care impacts
of ED, including work productivity and impairment (Lynch et al., 2010;
Mond & Hay, 2007); however, speciﬁc estimates of lost productivity as-
sociatedwith EDare still lacking. In a recent reviewof 18 economic eval-
uations of ED (Stuhldreher, 2012), none evaluated lost productivity in
the US. Researchers are beginning to recognize that additional evidence
of the full economic costs of ED is needed to more accurately evaluate
the overall burden of disease and the cost-effectiveness of emerging
ED treatment and prevention interventions (Crow, 2014). In this
exploratory study, we measure the impact of ED on health care costs,
employment status, and earnings in the US. We further explore theM. Samnaliev).
. This is an open access article undercontribution of mental health comorbidities to these disparities in
health care costs and lost productivity.
Methods
We used 5 years of data from the representative Medical Expendi-
tures Panel Survey (MEPS) of the civilian non-institutionalized US
population, which collects demographic, diagnostic, health care utiliza-
tion, and associated cost data annually.We included all age groups (0 to
85), in order to estimate excess health care costs, adjusting for inﬂation
(Bureau of Labor Statistics, 2012), representative of the entire US
population with ED. We included a broad range of eating and related
disorders, including anorexia nervosa (International Classiﬁcation of
Diseases, Ninth Revision (ICD-9) (Classiﬁcation of Diseases and
Injuries, 2014) 3071), bulimia nervosa or binge eating (ICD-9 30751),
pica (ICD-9 30752), other eating disorders (ICD-9 30750, 30759), rumi-
nation disorder (ICD-9 30753) and psychogenic vomiting (ICD-9
30754). We identiﬁed mental health comorbidities, including schizo-
phrenia, bipolar disorder, or major depression and a broad range of
non-severe mental health disorders (ICD-9 codes 295.x to 302.x and
306.x to 315.x, excluding ED). We extracted total health care costs for
all care provided during each calendar year. MEPS also collects data onthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Characteristics of respondents to the Medical Expenditure Panel Survey, 2007–2011.
MEPS respondents MEPS respondents with ED
No ED N = 168,865 ED N = 86 No MH comorbidity N = 52 Had MH comorbidity N = 34
Age, mean (sd) 34.6 (22.4) 43.1 (21.5)⁎ 45.8 (21.8) 39.0 (20.6)
Female, % 52.1 36.1⁎ 21.2 58.8⁎⁎
Education years, mean (sd) 10.8 (4.6) 13.1 (3.6)⁎ 13.7 (3.1) 12.3 (4.2)
Household size, mean (sd) 3.6 (1.8) 2.7 (1.5)⁎ 2.8 (1.6) 2.6 (1.3)
White, % 70.2 84.9⁎ 82.7 88.2
MEPS =Medical Expenditures Panel Survey.
ED = eating disorders.
⁎ p b .05 compared to MEPS respondents without ED.
⁎⁎ p b .05 compared to MEPS respondents with ED who did not have behavioral health comorbidity. Statistical tests were conducted using non-parametric Mann–Whitney U tests for
continuous and exact Fisher's test for categorical variables.
Table 2
Annual health care costsa, odds of employment and earnings (2011 US$) associated with ED and mental health comorbidities.
MEPS respondents MEPS respondents with ED
No ED ED Differenceb
95% CI (p-value)
No MH comorbidity MH comorbidity Differenceb
95% CI (p-value)
Annual health care costs $3910 $5779 $1869 $5033 $7026 $1993
$96 to $3641 (0.012) −$1445 to $5433 (0.17)
Odds ratio of being employed
over past 12 monthsc
0.67 0.41
0.41 to 1.09 (0.10) (0.14 to 1.20) (0.10)
Annual wage incomed $29,872 $27,779 $2093 $39,938 $20,564 $19,374
−$3517 to $7703 (0.48) $4155 to $34,592 (b0.001)
MEPS =Medical Expenditures Panel Survey; ED = eating disorders.
a All costs were inﬂation adjusted to 2011 US $ using the Price Index of the Bureau of Labor Statistics and the general inﬂation rate from the BLS.
b Controlling for age, gender, race/ethnicity, household size and years of education.
c Among MEPS respondents of age 18 years or above (48 respondents had ED).
d Among MEPS respondents of age 18 years or above who were employed.
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assumed that the person was employed if he or she reported earned
income through either gainful employment or self-employment in the
respective year.
We ﬁrst compared the characteristics of all MEPS respondents with
ED and those without ED using non-parametric Mann–Whitney U
tests for age, years of education and household size and exact Fisher's
test for gender and race/ethnicity. We then estimated the additional
health care costs among all MEPS respondents (ages 0–85) and odds
of employment (among those of age 18 years or above). Finally, we
estimated differences in annual earnings (among individuals of age
18 years or above who were employed within the past 12 months)
between individuals with ED and those without ED. The estimations
above relied on generalized linear regression models with a log link –
to address non-normality of the data and mitigate the effect of the
skewed distribution that characterize cost data – and gamma distribu-
tion for costs and earnings and binary distribution with a logit link
(Manning & Mullahy, 2001) to estimate the odds of being employed.
Thesemodels adjusted for several potential confounderswhich in theory
are linked with health care utilization and earnings: age, gender, race/
ethnicity, household size, and number of years of education. We applied
the samemodels among a subset of individualswith ED to contrast those
with and without mental health comorbidities and to estimate their ad-
ditional health care costs, odds of being employed and earnings. As this
was a small exploratory study, we adopted a low threshold of p b 0.10
to evaluate statistical signiﬁcance.
Results
Of 168,951 women and men ages 0 to 85 in MEPS 2007 to 2011, 86
(0.05%) were identiﬁed to currently have ED1. Of these individuals 341 Other studies have also reported relatively low point prevalence of ED (Smink et al.,
2012); ours may be even lower as it was assessed at the average age of 43.1 years which
is substantially above the average age of onset of ED.(39.5%) had at least one mental health comorbidity. Individuals with
ED compared to those without ED, were older and less likely to be
female. The latter might be related to the average age of our sample of
individuals with ED (43.1 years, which exceeds the typical age of ED
onset) and suggests that point prevalence of ED in that age group
might be higher among men than women. Individuals with ED were
also slightly more educated and more likely to be white as opposed to
other race or ethnicity (Table 1). These differences were not signiﬁcant
when MEPS respondents with ED and mental health comorbidities
were contrasted to those with ED only, with the exception of gender;
females with ED were much more likely to have mental health comor-
bidity than males with ED (p b 0.01).
Annual health care costs were $1869 greater (p = 0.012) among
individuals with ED compared to the general population (Table 2). In
addition, individuals with ED (of ages 18 years or above) were less
likely to report any earnings in the past 12 months, compared to
individuals without ED, although this effect was borderline signiﬁ-
cant (OR = 0.67, 95% CIs [0.41, 1.09]). Among the subgroup of
MEPS respondents with ED who were employed at least for some
time in the past 12 months, annual earnings were $2093 lower but
not statistically signiﬁcant (p = 0.48) compared to MEPS respondents
without ED.
Having mental health comorbidities was associated with $1993
increased annual costs when contrasted to individuals with ED and
no comorbidities. Although large, that difference was not signiﬁcant
(p= 0.17), perhaps due to the small sample size and power to detect
such differences in costs. Similarly, the presence of mental health
comorbidities was associated with 59% lower probability of being
employed (OR = 0.41, 95% CIs [0.14, 1.20]). These large differences
however were on the borderline of statistical signiﬁcance (assuming
a 0.10 cutoff for an exploratory study) again possibly because of the
small sample size. On the other hand, among those with ED, the
presence of mental health comorbidity was associated with almost
two times lower annual earnings (difference of $19,374, p b 0.01,
Table 2).
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Decision makers increasingly rely on economic evaluations to set
public health priorities and to determine the relative value and cost-
effectiveness of new screening, treatment, and prevention modalities.
Direct costs of ED treatment have been previously documented
(Mitchell et al., 2009; Striegel-Moore et al., 2000) but are only a fraction
of the overall economic impact associated with the disease. Accordingly,
our analysis suggests that employment rates may be lower among indi-
viduals with ED than those without ED. The overall loss in earnings asso-
ciated with ED was greater in magnitude to the excess health care
costs associated with the disease (34% lower odds of working
compounded with an annual wage decrement of $2903 if working,
compared to $1869 in excess health care costs), which further points
to the need to incorporate these non-health impacts into evaluations
and decision making processes.
Mental health comorbidities in our sample (point prevalence of
39.5%) substantially exceeded the background prevalence of mental
health disorders reported in the general US population (Kessler et al.,
1994) and seemed to contribute considerably to the differences in
health care costs, employment status, and earnings between individuals
with ED and other MEPS respondents. Therefore evaluations of the eco-
nomic burden of ED need to also consider the wider impacts on overall
mental health, such as anxiety and depression. Similarly, evaluations of
the cost-effectiveness of ED treatment and prevention need to incorpo-
rate the health beneﬁts and savings associated with improved mental
health more broadly.
Our ﬁndings should be viewed primarily as a rationale for conducting
large scale evaluations of the economic burden of ED and associated
comorbidities that include measures of employment and earnings.
Such evaluations will likely demonstrate that investment in ED treat-
ment and prevention has broader economic beneﬁts and is more cost-
effective from a societal perspective than previously recognized.
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